These data are well supported by the findings of Imaeda et al,16 who in an acetaminophen-induced hepatotoxicity model, established that inhibition of TLR9 using ODN2088 and IRS954, a TLR7/9 antagonist, downregulated proinflammatory cytokine release and reduced mortality. The gene discussed is TLR9; the disease is hepatotoxicity.